WASHINGTON (MedPage Today) -- The FDA has approved a 13-valent version of the pneumococcal conjugate vaccine Prevnar for use in pediatric patients 6 months to 5 years old.
New Version of Pneumococcal Vaccine Gets OkayCourtesy MedPage Today Infectious Disease Wed, 02/24/2010 - 13:05
WASHINGTON (MedPage Today) -- The FDA has approved a 13-valent version of the pneumococcal conjugate vaccine Prevnar for use in pediatric patients 6 months to 5 years old. More related itemsRepeat Exam May Shed More Light on Sex Abuse (CME/CE)
FDA OKs New Use for Aortic Graft
FDA Holds OJ Imports Pending Fungicide Testing
|
Popular by tags WeekMonth |
Post new comment